← Back to Intel
Insider ActivityLXEO
Townsend Richard Nolan, Chief Executive Officer at Lexeo Therapeutics, Inc., sold $313K of LXEO
Updated Jun 14, 2026
Townsend Richard Nolan
Chief Executive Officer
Lexeo Therapeutics, Inc. ·
$LXEO
Transaction Details
| Insider | Townsend Richard Nolan |
|---|---|
| Title | Chief Executive Officer |
| Company | Lexeo Therapeutics, Inc. |
| Ticker | LXEO |
| Transaction Type | Sale |
| Transaction Date | 2026-04-06 |
| Shares Traded | 55,000 |
| Price Per Share | $5.6934 |
| Total Value | $313K |
| Filed Date | 2026-04-07 |
| Accession Number | 0001995218-26-000009 |
Ownership Context
| Shares Owned After Transaction | 340,106 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001995218-26-000009
Other Insider Trades — LXEO
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Otero Jose Manuel | Chief Operating Officer | sold | $7K | 2026-05-18 |
| Townsend Richard Nolan | Chief Executive Officer | sold | $17K | 2026-05-18 |
| Sepp-Lorenzino Laura | Insider | traded | — | 2026-04-28 |
Other Trades by Townsend Richard Nolan
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | sold | $17K | 2026-05-18 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for LXEO — Lexeo Therapeutics, Inc. →
Track LXEO insider activity in real time on The Wire →
Get alerts when Townsend Richard Nolan files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 14, 2026 at 07:19 UTC